Drug Discovery Market Expected To Reach $250.5 Billion By 2030 As Growth Accelerates At 15.1% CAGR
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Drug Discovery Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The drug discovery market has seen a notable surge in scale over recent times. Its value is projected to climb from $124.11 billion in 2025 to $142.54 billion in 2026, reflecting a compound annual growth rate (CAGR) of 14.8%. This historical expansion has been largely driven by a rising incidence of chronic and infectious conditions, progress in molecular biology methods, increased investment in research and development from pharmaceutical firms, heightened partnerships within the biotechnology sector, and accessible research funding.
The market for drug discovery is projected to experience significant expansion in the coming years, with its size anticipated to reach $250.51 billion by 2030, driven by a compound annual growth rate (CAGR) of 15.1%. This growth during the forecast period is fueled by the rise of AI-driven drug discovery platforms, the broadening scope of personalized medicine, the use of omics data in drug design, increased biopharmaceutical outsourcing, and the integration of automation and robotics into laboratory settings. Key trends shaping the forecast period comprise progress in high-throughput screening, the development of targeted therapies, adoption of personalized medicine strategies, incorporation of pharmacogenomics, and drug discovery enabled by nanotechnology.
Download A Free Sample Report For Comprehensive Market Insights:
Drug Discovery Market Growth Drivers: What Factors Are Accelerating Expansion?
The drug discovery market is anticipated to be driven forward by increasing healthcare spending. Nations across the globe are allocating a substantial portion of their GDP to health-related costs, covering areas such as hospital care, physician and clinical services, other professional services, dental care, additional health services, residential and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription medications, and more. Drug discovery constitutes a significant component of these health expenditures, as it is essential for treating illnesses and extending life expectancy. A growing demand exists for novel pharmaceuticals to address emerging diseases. For example, in October 2024, the Centers for Medicare and Medicaid Services, a federal agency in the United States, reported that national health expenditure rose by 4.1% to $4.5 trillion in 2022, equating to $13,493 per person. Between 2023 and 2032, the average annual growth in national health spending (5.6%) is expected to exceed the average GDP growth rate (4.3%), leading to an increase in the health spending share of GDP from 17.3% in 2022 to 19.7% in 2032. Consequently, the expansion of healthcare expenditures is fueling growth in the drug discovery market.
Drug Discovery Market Segmentation And Category Breakdown
The drug discovery market covered in this report is segmented –
1) By Drug Type: Small Molecule, Large Molecule
2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation
3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies
4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas
5) By End User: Pharmaceutical Companies, CROs, Other End-Users
Subsegments:
1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs
2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies
Drug Discovery Market Trends: What Is Shaping Future Industry Growth?
Key players in the drug discovery sector are introducing a range of innovative technologies—including artificial intelligence and imaging methods—with the aim of shortening the timeline needed for medication development. Through imaging technology, non-invasive visualization, characterization, and quantification of biological processes triggered by drugs inside living organisms becomes possible. Such techniques, which harness the capabilities of probes or the body’s own tissues, play a vital role in comprehending diseases and identifying novel therapeutic options. A case in point is May 2023, when Google Cloud unveiled two new AI-based platforms: the Target and Lead Identification Suite and the Multiomics Suite. These are intended to speed up drug discovery and enhance precision medicine. Specifically, the Target and Lead Identification Suite helps determine the roles of amino acids and proteins, whereas the Multiomics Suite expedites genetic data analysis and interpretation, thereby supporting the creation of more targeted treatments.
Drug Discovery Market Competitive Analysis Of Major Industry Participants
Major companies operating in the drug discovery market are Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.
Access The Complete Drug Discovery Market Report:
Drug Discovery Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the drug discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
